What is the brand name for Amantadine (antiviral medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Amantadine is available under several brand names, with Symmetrel being the most well-known and historically significant brand name in the United States. Other brand names for amantadine include Gocovri (an extended-release formulation), Osmolex ER (another extended-release version), and PK-Merz. Amantadine is an antiviral medication that also has effects on the central nervous system, making it useful for treating both influenza A infections and Parkinson's disease symptoms. It's also used to manage drug-induced extrapyramidal symptoms and for treatment of fatigue in multiple sclerosis. When prescribed, the typical dosage for Parkinson's disease is 100 mg once or twice daily, while for influenza prevention or treatment, it's usually 200 mg daily in divided doses, as noted in older studies such as 1. However, more recent guidelines, such as 1, suggest that amantadine and rimantadine are not recommended for antiviral treatment or chemoprophylaxis of currently circulating influenza A virus strains due to widespread adamantane resistance. The medication works by increasing dopamine release and blocking dopamine reuptake in the brain, which helps improve motor function in Parkinson's patients. For viral infections, it prevents the virus from replicating by blocking the uncoating of the viral RNA. Key points to consider when prescribing amantadine include:

  • Its effectiveness against influenza A viruses
  • Its limited use due to resistance among current influenza A strains, as highlighted in 1
  • Its potential benefits for Parkinson's disease and other conditions
  • The importance of monitoring for side effects and adjusting dosages as needed.

From the FDA Drug Label

Amantadine Hydrochloride Oral Solution USP is designated generically as amantadine hydrochloride The brand name for amantadine is not explicitly stated in the provided drug labels 2 2.

From the Research

Brand Name for Amantadine

  • The brand name for amantadine is Symmetrel, as mentioned in the study 3.
  • This study published in 1976, refers to amantadine hydrochloride as Symmetrel, an antiviral and antiparkinson agent.
  • There is no other brand name mentioned for amantadine in the provided studies 4, 5, 6, 7.
  • These studies focus on the effectiveness and safety of amantadine and rimantadine in preventing and treating influenza A, but do not provide additional information on brand names.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1976

Research

Influenza viruses - antiviral therapy and resistance.

GMS infectious diseases, 2017

Research

Amantadine and rimantadine for influenza A in children and the elderly.

The Cochrane database of systematic reviews, 2014

Research

Amantadine and rimantadine for preventing and treating influenza A in adults.

The Cochrane database of systematic reviews, 2002

Research

Clinical use of approved influenza antivirals: therapy and prophylaxis.

Influenza and other respiratory viruses, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.